The pulmonary symptoms of participants with tobacco exposure and preserved spirometry (TEPS) at the start of the study persisted through more than five years of follow-up, the researchers found.
New Delhi: Cadlia Healthcare Ltd on Monday said group firm Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market its generic version of Roflumilast tablets in the strength of 500 mcg indicated to reduce the risk of chronic obstructive pulmonary disease (COPD) exacerbations. Zydus, being one of the first […]
